Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis
about
Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysisResponse Tailored Protocol Versus the Fixed 12Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial.Letter: the efficacy of interferon-free regimens in HCV-related Child C cirrhosis needs careful interpretation.
P2860
Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@ast
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@en
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@nl
type
label
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@ast
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@en
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@nl
prefLabel
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@ast
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@en
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@nl
P2860
P31
P3181
P356
P1433
P1476
Daclatasvir-based Treatment Re ...... matic Review and Meta-Analysis
@en
P2860
P304
P3181
P356
10.5812/HEPATMON.41077
P407
P577
2016-08-22T00:00:00Z